首页 > 最新文献

Recent patents on biotechnology最新文献

英文 中文
Impact of COVID-19 on Brain and Psychological Health, its Possible Mechanisms, and Coping Strategies. COVID-19对大脑和心理健康的影响、可能的机制和应对策略
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220617110402
Faizan Zarreen Simnani, Dibyangshee Singh, Anmol Choudhury, Ansab Akhtar

COVID-19 pandemic has been depicted to possess a robust association with psychological disorders. SARS-CoV-2 is the most recent virus of the coronavirus family and has the potential to bind the angiotensin-converting enzyme (ACE) receptor. The receptor is mainly present peripherally and to some extent in the brain. Different psychological and neurodegenerative disorders can arise due to the peripheral origin of destruction. These triggers could be inflammatory pathways releasing pro-inflammatory cytokines reaching the brain and causing neuroinflammation. In continuation with traditional viruses, SARS-CoV-2 too might lead to brain diseases like meningitis, encephalitis, etc. Besides, several peripheral hormonal changes like cortisol can influence neurochemical alterations, thereby inflicting mood-related activities and psychological phenomena. In this regard, health care workers, frontline line warriors and relatives of COVID-19 patients can be the secondary victims; however, patients with COVID-19 remain the primary ones prone to neurological health problems. Several strategies like socialization, engagement, physical activity, etc., are well-opted measures to get relief from and check psychiatric disturbances. The worth of this review can be attributed to the understanding of brain-related mechanisms of COVID-19 in the context of its mechanism of action to create the pathology pertaining to brain disorder, precisely psychological devastation. Likewise, its epidemiological relevance has concisely been mentioned. Furthermore, different categories and classes of people prone to psychological deterioration are briefly elaborated on. Lastly, some coping strategies and approaches have been discussed to minimize or combat mental health problems.

COVID-19大流行已被描述为与心理障碍密切相关。SARS-CoV-2是冠状病毒家族中最新的病毒,具有结合血管紧张素转换酶(ACE)受体的潜力。受体主要存在于外周,并在一定程度上存在于大脑中。不同的心理和神经退行性疾病可因外周起源的破坏而产生。这些触发因素可能是释放促炎细胞因子到达大脑并引起神经炎症的炎症途径。与传统病毒一样,SARS-CoV-2也可能导致脑膜炎、脑炎等脑部疾病。此外,一些外围激素的变化,如皮质醇,可以影响神经化学变化,从而造成与情绪相关的活动和心理现象。在这方面,医护人员、一线战士和COVID-19患者家属可能成为次要受害者;然而,COVID-19患者仍然是容易出现神经健康问题的主要人群。一些策略,如社会化,参与,体育活动等,是缓解和检查精神障碍的良好选择措施。这篇综述的价值可归因于对COVID-19脑相关机制的理解,在其作用机制的背景下,它产生了与大脑疾病有关的病理,确切地说是心理破坏。同样,它与流行病学的关系也已简明地提到。此外,简要阐述了不同类别和类别的人容易心理恶化。最后,讨论了一些应对策略和方法,以尽量减少或打击心理健康问题。
{"title":"Impact of COVID-19 on Brain and Psychological Health, its Possible Mechanisms, and Coping Strategies.","authors":"Faizan Zarreen Simnani,&nbsp;Dibyangshee Singh,&nbsp;Anmol Choudhury,&nbsp;Ansab Akhtar","doi":"10.2174/1872208316666220617110402","DOIUrl":"https://doi.org/10.2174/1872208316666220617110402","url":null,"abstract":"<p><p>COVID-19 pandemic has been depicted to possess a robust association with psychological disorders. SARS-CoV-2 is the most recent virus of the coronavirus family and has the potential to bind the angiotensin-converting enzyme (ACE) receptor. The receptor is mainly present peripherally and to some extent in the brain. Different psychological and neurodegenerative disorders can arise due to the peripheral origin of destruction. These triggers could be inflammatory pathways releasing pro-inflammatory cytokines reaching the brain and causing neuroinflammation. In continuation with traditional viruses, SARS-CoV-2 too might lead to brain diseases like meningitis, encephalitis, etc. Besides, several peripheral hormonal changes like cortisol can influence neurochemical alterations, thereby inflicting mood-related activities and psychological phenomena. In this regard, health care workers, frontline line warriors and relatives of COVID-19 patients can be the secondary victims; however, patients with COVID-19 remain the primary ones prone to neurological health problems. Several strategies like socialization, engagement, physical activity, etc., are well-opted measures to get relief from and check psychiatric disturbances. The worth of this review can be attributed to the understanding of brain-related mechanisms of COVID-19 in the context of its mechanism of action to create the pathology pertaining to brain disorder, precisely psychological devastation. Likewise, its epidemiological relevance has concisely been mentioned. Furthermore, different categories and classes of people prone to psychological deterioration are briefly elaborated on. Lastly, some coping strategies and approaches have been discussed to minimize or combat mental health problems.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"62-79"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10864132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Accelerating Drug Discovery and Development. 人工智能在加速药物发现和开发中的应用。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220802151129
Anushree Tripathi, Krishna Misra, Richa Dhanuka, Jyoti Prakash Singh

Drug discovery and development are critical processes that enable the treatment of wide variety of health-related problems. These are time-consuming, tedious, complicated, and costly processes. Numerous difficulties arise throughout the entire process of drug discovery, from design to testing. Corona Virus Disease 2019 (COVID-19) has recently posed a significant threat to global public health. SARS-Cov-2 and its variants are rapidly spreading in humans due to their high transmission rate. To effectively treat COVID-19, potential drugs and vaccines must be developed quickly. The advancement of artificial intelligence has shifted the focus of drug development away from traditional methods and toward bioinformatics tools. Computer-aided drug design techniques have demonstrated tremendous utility in dealing with massive amounts of biological data and developing efficient algorithms. Artificial intelligence enables more effective approaches to complex problems associated with drug discovery and development through the use of machine learning. Artificial intelligence-based technologies improve the pharmaceutical industry's ability to discover effective drugs. This review summarizes significant challenges encountered during the drug discovery and development processes, as well as the applications of artificial intelligence-based methods to overcome those obstacles in order to provide effective solutions to health problems. This may provide additional insight into the mechanism of action, resulting in the development of vaccines and potent substitutes for repurposed drugs that can be used to treat not only COVID-19 but also other ailments.

药物发现和开发是能够治疗各种与健康有关的问题的关键过程。这些都是耗时、乏味、复杂和昂贵的过程。从设计到测试,在药物发现的整个过程中会出现许多困难。2019冠状病毒病(COVID-19)最近对全球公共卫生构成重大威胁。由于SARS-Cov-2及其变体的高传播率,它们正在人类中迅速传播。为了有效治疗COVID-19,必须迅速开发潜在的药物和疫苗。人工智能的进步使药物开发的重点从传统方法转向生物信息学工具。计算机辅助药物设计技术在处理大量生物数据和开发高效算法方面显示出巨大的效用。通过使用机器学习,人工智能能够更有效地解决与药物发现和开发相关的复杂问题。基于人工智能的技术提高了制药行业发现有效药物的能力。本综述总结了在药物发现和开发过程中遇到的重大挑战,以及基于人工智能的方法的应用,以克服这些障碍,以便为健康问题提供有效的解决方案。这可能会对作用机制提供更多的了解,从而开发出疫苗和有效的替代药物,不仅可用于治疗COVID-19,还可用于治疗其他疾病。
{"title":"Artificial Intelligence in Accelerating Drug Discovery and Development.","authors":"Anushree Tripathi,&nbsp;Krishna Misra,&nbsp;Richa Dhanuka,&nbsp;Jyoti Prakash Singh","doi":"10.2174/1872208316666220802151129","DOIUrl":"https://doi.org/10.2174/1872208316666220802151129","url":null,"abstract":"<p><p>Drug discovery and development are critical processes that enable the treatment of wide variety of health-related problems. These are time-consuming, tedious, complicated, and costly processes. Numerous difficulties arise throughout the entire process of drug discovery, from design to testing. Corona Virus Disease 2019 (COVID-19) has recently posed a significant threat to global public health. SARS-Cov-2 and its variants are rapidly spreading in humans due to their high transmission rate. To effectively treat COVID-19, potential drugs and vaccines must be developed quickly. The advancement of artificial intelligence has shifted the focus of drug development away from traditional methods and toward bioinformatics tools. Computer-aided drug design techniques have demonstrated tremendous utility in dealing with massive amounts of biological data and developing efficient algorithms. Artificial intelligence enables more effective approaches to complex problems associated with drug discovery and development through the use of machine learning. Artificial intelligence-based technologies improve the pharmaceutical industry's ability to discover effective drugs. This review summarizes significant challenges encountered during the drug discovery and development processes, as well as the applications of artificial intelligence-based methods to overcome those obstacles in order to provide effective solutions to health problems. This may provide additional insight into the mechanism of action, resulting in the development of vaccines and potent substitutes for repurposed drugs that can be used to treat not only COVID-19 but also other ailments.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"9-23"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10872414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Cypermethrin Toxicity-induced Infertility: An Assessment of Longitudinal Transfer of Protective Potentials of Date Fruit Extracts in Wister Rats. 氯氰菊酯毒性致不育:枣果实提取物对Wister大鼠保护电位纵向转移的评价。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220817092827
Simon A Ubah, Oluwa A Agbonu, Philemon K Columbus, Kenneth O Abah, Ijeoma C Chibuogwu, Abayomi S Bankole, Simon I Enem, Charles E Ejiofor, Isaac O Akefe, Itopa E Ajayi

Background: There is a potential for longitudinal and horizontal transfer of the cytotoxic effects of cypermethrin, and evidence suggests that date fruit extracts can ameliorate these cytotoxic effects. Thus, the current study evaluated female Wister rats' fertility and pup parameters after mating males treated with cypermethrin and date fruit (Phoenix dactylifera) extract.

Methods: Adult Wistar rats (n = 74; 140 - 207 g) were used to conduct this experiment in two phases: The first phase was a single dose toxicity study (n = 18), while the second phase (n = 56) evaluated female Wister rats' reproductive and pup development parameters after mating with male Wistar rats exposed to date fruit extract and cypermethrin. Male rats were distributed randomly into four groups (n = 7 per group) and administered distilled water (Group I); 60 mg/kg cypermethrin (Group II) to simulate infertility; 250 mg/kg date fruit extract alone (Group III); and date fruit extracts plus 60 mg/kg cypermethrin (Group IV). Treated males were then mated with healthy female rats at a ratio of 1:1. Successfully mated females were appraised for conception and pregnancy rates, gestation length, litter size, and weights at birth, and on days 5, 10, 15, and 21 post-partum, an anogenital distance at day-20, sex ratio, and age of pup when hair growth was evident.

Results: Significant differences (p < 0.05) were observed in litter size and male anogenital distance but not in reproductive performance. Also, the study demonstrated that date fruit extract skewed the sex ratio of offspring to more female than male pups when female Wister rats were mated with males that received date fruit extracts alone or cypermethrin and date fruit extracts. The body weight gain did not differ significantly between the control and cypermethrin-treated groups.

Conclusion: This evidence suggested a longitudinal transfer of the protective effects of date fruit extracts following a weekly exposure of male rats to cypermethrin at 60 mg/kg.

背景:氯氰菊酯的细胞毒性作用可能存在纵向和横向转移,有证据表明枣果实提取物可以改善这些细胞毒性作用。因此,本研究评估了用氯氰菊酯和枣子提取物处理雄性Wister大鼠交配后雌性Wister大鼠的生育能力和幼仔参数。方法:成年Wistar大鼠74只;本实验共分两期进行:第一期为单剂量毒性研究(n = 18),第二期(n = 56)为雌性Wistar大鼠与雄性Wistar大鼠交配后对枣子提取物和氯氰菊酯的生殖和幼仔发育参数的评价。雄性大鼠随机分为4组(每组7只),给予蒸馏水(第一组);氯氰菊酯(II组)60 mg/kg模拟不孕症;单独椰枣提取物250 mg/kg (III组);红枣提取物加60 mg/kg氯氰菊酯(IV组)。处理后的雄鼠与健康雌鼠按1:1的比例交配。对成功交配的雌性进行受孕率、受孕率、妊娠期、产仔数、出生时体重、产后第5、10、15和21天、第20天的肛门生殖器距离、性别比例和幼犬年龄(毛发生长明显)的评估。结果:产仔数、雄性肛门生殖器距离差异有统计学意义(p < 0.05),繁殖性能差异无统计学意义(p < 0.05)。此外,研究表明,当雌性Wister大鼠与单独服用枣子提取物或氯氰菊酯加枣子提取物的雄性交配时,枣子提取物扭曲了后代的性别比例,雌性大于雄性。体重增加在对照组和氯氰菊酯处理组之间没有显著差异。结论:该证据表明,雄性大鼠每周暴露于60mg /kg的氯氰菊酯后,枣果提取物的保护作用会纵向转移。
{"title":"Cypermethrin Toxicity-induced Infertility: An Assessment of Longitudinal Transfer of Protective Potentials of Date Fruit Extracts in Wister Rats.","authors":"Simon A Ubah,&nbsp;Oluwa A Agbonu,&nbsp;Philemon K Columbus,&nbsp;Kenneth O Abah,&nbsp;Ijeoma C Chibuogwu,&nbsp;Abayomi S Bankole,&nbsp;Simon I Enem,&nbsp;Charles E Ejiofor,&nbsp;Isaac O Akefe,&nbsp;Itopa E Ajayi","doi":"10.2174/1872208316666220817092827","DOIUrl":"https://doi.org/10.2174/1872208316666220817092827","url":null,"abstract":"<p><strong>Background: </strong>There is a potential for longitudinal and horizontal transfer of the cytotoxic effects of cypermethrin, and evidence suggests that date fruit extracts can ameliorate these cytotoxic effects. Thus, the current study evaluated female Wister rats' fertility and pup parameters after mating males treated with cypermethrin and date fruit (Phoenix dactylifera) extract.</p><p><strong>Methods: </strong>Adult Wistar rats (n = 74; 140 - 207 g) were used to conduct this experiment in two phases: The first phase was a single dose toxicity study (n = 18), while the second phase (n = 56) evaluated female Wister rats' reproductive and pup development parameters after mating with male Wistar rats exposed to date fruit extract and cypermethrin. Male rats were distributed randomly into four groups (n = 7 per group) and administered distilled water (Group I); 60 mg/kg cypermethrin (Group II) to simulate infertility; 250 mg/kg date fruit extract alone (Group III); and date fruit extracts plus 60 mg/kg cypermethrin (Group IV). Treated males were then mated with healthy female rats at a ratio of 1:1. Successfully mated females were appraised for conception and pregnancy rates, gestation length, litter size, and weights at birth, and on days 5, 10, 15, and 21 post-partum, an anogenital distance at day-20, sex ratio, and age of pup when hair growth was evident.</p><p><strong>Results: </strong>Significant differences (p < 0.05) were observed in litter size and male anogenital distance but not in reproductive performance. Also, the study demonstrated that date fruit extract skewed the sex ratio of offspring to more female than male pups when female Wister rats were mated with males that received date fruit extracts alone or cypermethrin and date fruit extracts. The body weight gain did not differ significantly between the control and cypermethrin-treated groups.</p><p><strong>Conclusion: </strong>This evidence suggested a longitudinal transfer of the protective effects of date fruit extracts following a weekly exposure of male rats to cypermethrin at 60 mg/kg.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 2","pages":"176-185"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9465640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Patent Landscape of Polyhydroxyalkanoates Production by Algae and Cyanobacteria. 藻类和蓝藻生产聚羟基烷酸酯的专利景观。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666221207145011
Dielle Pierotti Procópio, Letícia Oliveira Bispo Cardoso, Bruna Bacaro Borrego, Louise Hase Gracioso, Claudio Augusto Oller Nascimento, Elen Aquino Perpetuo, Cassius Vinicius Stevani, Renato Sanches Freire

Background: As global awareness regarding climate change and environmental pollution outcomes arise, eco-friendly and negative emission technologies emerge.

Methods: In this scenario, polyhydroxyalkanoate (PHA)-accumulating microorganisms play an important role in the transition from the petrochemical-based non-biodegradable polymer to renewable, eco-friendly, and biocompatible materials. More specifically, CO2 can be converted to biopolymers through photosynthesis by cyanobacteria and algae, posing as a promising technology for renewable material, CO2, and petroleum-dependence mitigations. However, although many microorganisms can accumulate PHA intracellularly, limitations persist, such as the elevated cost and limited market availability.

Results: Herein is presented a patent-based mapping on technological trends of PHAs production, including its production by microalgae and cyanobacteria using the Questel Orbit Intelligence software (version 1.9.8) in complement with the Espacenet Patent Search database.

Conclusion: The inquiry on PHAs retrieved 34,243 patents filed since 1912, whereas 156 are related to their specific production by photosynthetic microorganisms, evidencing a prospective market for intellectual property.

背景:随着全球对气候变化和环境污染后果的认识提高,环保和负排放技术应运而生。方法:在这种情况下,聚羟基烷酸酯(PHA)积累微生物在从石化基不可生物降解聚合物到可再生、环保和生物相容性材料的转变中发挥了重要作用。更具体地说,二氧化碳可以通过蓝藻和藻类的光合作用转化为生物聚合物,这是一项有前途的可再生材料、二氧化碳和石油依赖缓解技术。然而,尽管许多微生物可以在细胞内积累PHA,但局限性仍然存在,例如成本升高和市场供应有限。结果:本文利用Questel Orbit Intelligence软件(版本1.9.8)和Espacenet专利检索数据库,对pha生产的技术趋势进行了基于专利的映射,包括微藻和蓝藻的生产。结论:自1912年以来,对pha的调查检索到34,243项专利,其中156项与光合微生物的特定生产有关,证明了知识产权的潜在市场。
{"title":"The Patent Landscape of Polyhydroxyalkanoates Production by Algae and Cyanobacteria.","authors":"Dielle Pierotti Procópio,&nbsp;Letícia Oliveira Bispo Cardoso,&nbsp;Bruna Bacaro Borrego,&nbsp;Louise Hase Gracioso,&nbsp;Claudio Augusto Oller Nascimento,&nbsp;Elen Aquino Perpetuo,&nbsp;Cassius Vinicius Stevani,&nbsp;Renato Sanches Freire","doi":"10.2174/1872208317666221207145011","DOIUrl":"https://doi.org/10.2174/1872208317666221207145011","url":null,"abstract":"<p><strong>Background: </strong>As global awareness regarding climate change and environmental pollution outcomes arise, eco-friendly and negative emission technologies emerge.</p><p><strong>Methods: </strong>In this scenario, polyhydroxyalkanoate (PHA)-accumulating microorganisms play an important role in the transition from the petrochemical-based non-biodegradable polymer to renewable, eco-friendly, and biocompatible materials. More specifically, CO<sub>2</sub> can be converted to biopolymers through photosynthesis by cyanobacteria and algae, posing as a promising technology for renewable material, CO<sub>2</sub>, and petroleum-dependence mitigations. However, although many microorganisms can accumulate PHA intracellularly, limitations persist, such as the elevated cost and limited market availability.</p><p><strong>Results: </strong>Herein is presented a patent-based mapping on technological trends of PHAs production, including its production by microalgae and cyanobacteria using the Questel Orbit Intelligence software (version 1.9.8) in complement with the Espacenet Patent Search database.</p><p><strong>Conclusion: </strong>The inquiry on PHAs retrieved 34,243 patents filed since 1912, whereas 156 are related to their specific production by photosynthetic microorganisms, evidencing a prospective market for intellectual property.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 3","pages":"271-288"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9818115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Action of Lactobacillus Probiotics Against Fungi of the Genus Candida: A Bibliographic Review. 益生乳杆菌对念珠菌属真菌的潜在作用:文献综述。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666221027093644
Milton Marcus Neves Sousa Carneiro Pimentel, Janaína de Carvalho Alves, Lúcio Henrique Sousa Pinheiro, Mariana Nougalli Roselino

Background: The use of Lactobacillus probiotics may confer beneficial effects on an individual's health, such as the ability to act against fungi of the genus Candida. There are about 200 species of those yeasts, and they can develop candidiasis infections, which affect about 75% of adult women.

Objective: This study aimed to raise articles that investigated the potential action of several Lactobacillus strains in front of Candida species.

Methods: For this review, 15 articles published between 2015 and 2020 were studied.

Results: The results showed the Lactobacillus species L. paracasei, L. acidophilus, L. helveticus, L. rhamnosus, L. reuteri, and L. gasseri have the potential action to inhibit the growth and quantity of colony-forming units of Candida species in vitro studies. Further, they can reduce the rate of candidiasis recurrence and increase the cure rate, mainly when associated with traditional pharmacotherapy, as observed in vivo studies.

Conclusion: The time of use and the strain of Lactobacillus probiotics can also be determining factors for the efficiency in the treatment against Candida species, suggesting that a long time of use of Lactobacillus probiotics is directly associated with a better result.

背景:使用益生乳杆菌可能对个人健康产生有益的影响,例如对抗念珠菌属真菌的能力。这些酵母菌大约有200种,它们会导致念珠菌感染,大约75%的成年女性会感染念珠菌。目的:研究几种乳酸菌对念珠菌的潜在作用。方法:本综述选取2015 - 2020年间发表的15篇文献为研究对象。结果:体外实验结果表明,副干酪乳杆菌、嗜酸乳杆菌、helveticus、鼠李糖乳杆菌、罗伊氏乳杆菌和加色乳杆菌具有抑制念珠菌生长和菌落形成单位数量的潜在作用。此外,根据体内研究,它们可以降低念珠菌病的复发率并提高治愈率,主要是在与传统药物治疗相结合的情况下。结论:益生乳杆菌的使用时间和菌种也可能是治疗念珠菌效果的决定因素,提示使用时间越长,效果越好。
{"title":"Potential Action of <i>Lactobacillus</i> Probiotics Against Fungi of the Genus <i>Candida</i>: A Bibliographic Review.","authors":"Milton Marcus Neves Sousa Carneiro Pimentel,&nbsp;Janaína de Carvalho Alves,&nbsp;Lúcio Henrique Sousa Pinheiro,&nbsp;Mariana Nougalli Roselino","doi":"10.2174/1872208317666221027093644","DOIUrl":"https://doi.org/10.2174/1872208317666221027093644","url":null,"abstract":"<p><strong>Background: </strong>The use of Lactobacillus probiotics may confer beneficial effects on an individual's health, such as the ability to act against fungi of the genus Candida. There are about 200 species of those yeasts, and they can develop candidiasis infections, which affect about 75% of adult women.</p><p><strong>Objective: </strong>This study aimed to raise articles that investigated the potential action of several Lactobacillus strains in front of Candida species.</p><p><strong>Methods: </strong>For this review, 15 articles published between 2015 and 2020 were studied.</p><p><strong>Results: </strong>The results showed the Lactobacillus species L. paracasei, L. acidophilus, L. helveticus, L. rhamnosus, L. reuteri, and L. gasseri have the potential action to inhibit the growth and quantity of colony-forming units of Candida species in vitro studies. Further, they can reduce the rate of candidiasis recurrence and increase the cure rate, mainly when associated with traditional pharmacotherapy, as observed in vivo studies.</p><p><strong>Conclusion: </strong>The time of use and the strain of Lactobacillus probiotics can also be determining factors for the efficiency in the treatment against Candida species, suggesting that a long time of use of Lactobacillus probiotics is directly associated with a better result.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 3","pages":"198-205"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9457061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Compact and Efficient Brine Shrimp Hatching Device. 一种小巧高效的卤虾孵化装置制造方法及图纸。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666230119100522
Alexander Machado Cardoso

Background: Artemia is considered an indispensable live food for rearing many fish and crustacean larvae and can be used in toxicity tests as a safe, practical, and economical method. It is straightforward to create and manipulate; however, many cysts do not hatch as expected.

Methods: A new device was used to hatch Artemia salina. The device includes a tubularshaped reservoir, lid with a central hole, heater with a thermostat, air compressor, three porous stones, funnel-shaped bottom, light source, collection valve, switch, and electrical outlet, which permits better control of temperature and aeration in a single apparatus. Different patent devices were used for comparative analysis.

Results: Hatched eggs of Artemia showed that the device was 97% efficient; in comparison, commercial and other devices hatched approximately less than 80% of the cysts. Although Artemia is an easy-to-handle animal, the device described here facilitates changes in the growth parameters and produces more nauplii larvae.

Conclusion: This paper presents a new device that is effective, compact, and successful for hatching brine shrimp cysts, thereby improving Artemia production.

背景:青蒿被认为是饲养许多鱼类和甲壳类动物幼虫不可缺少的活饲料,是一种安全、实用、经济的毒性试验方法。它很容易创建和操作;然而,许多囊肿不会像预期的那样孵化。方法:采用一种新型装置孵育盐渍蒿。该装置包括管状储水池、带中心孔的盖子、带恒温器的加热器、空气压缩机、三个多孔石头、漏斗形底部、光源、收集阀、开关和电源插座,从而可以更好地控制单个设备中的温度和通气。采用不同专利装置进行对比分析。结果:蒿卵孵化率为97%;相比之下,商业和其他设备孵化的囊肿大约不到80%。虽然Artemia是一种易于处理的动物,但这里描述的装置有助于改变生长参数,产生更多的nauplii幼虫。结论:本文提出了一种高效、紧凑、成功的盐水虾囊孵化装置,从而提高了青蒿的产量。
{"title":"A Compact and Efficient Brine Shrimp Hatching Device.","authors":"Alexander Machado Cardoso","doi":"10.2174/1872208317666230119100522","DOIUrl":"https://doi.org/10.2174/1872208317666230119100522","url":null,"abstract":"<p><strong>Background: </strong>Artemia is considered an indispensable live food for rearing many fish and crustacean larvae and can be used in toxicity tests as a safe, practical, and economical method. It is straightforward to create and manipulate; however, many cysts do not hatch as expected.</p><p><strong>Methods: </strong>A new device was used to hatch Artemia salina. The device includes a tubularshaped reservoir, lid with a central hole, heater with a thermostat, air compressor, three porous stones, funnel-shaped bottom, light source, collection valve, switch, and electrical outlet, which permits better control of temperature and aeration in a single apparatus. Different patent devices were used for comparative analysis.</p><p><strong>Results: </strong>Hatched eggs of Artemia showed that the device was 97% efficient; in comparison, commercial and other devices hatched approximately less than 80% of the cysts. Although Artemia is an easy-to-handle animal, the device described here facilitates changes in the growth parameters and produces more nauplii larvae.</p><p><strong>Conclusion: </strong>This paper presents a new device that is effective, compact, and successful for hatching brine shrimp cysts, thereby improving Artemia production.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 3","pages":"289-292"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9519065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicinal Plants Used for the Neutralization of Snake Venom in Northern Nigeria of West Africa. 西非尼日利亚北部用于中和蛇毒的药用植物。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220426120228
Ameh Matthew Philip, Yusuf Peter Ofemile, Akefe Isaac Oluwatobi, Ada Gabriel, Ugwoke Peter Ejiofor, Omar Hosea Aske
{"title":"Medicinal Plants Used for the Neutralization of Snake Venom in Northern Nigeria of West Africa.","authors":"Ameh Matthew Philip,&nbsp;Yusuf Peter Ofemile,&nbsp;Akefe Isaac Oluwatobi,&nbsp;Ada Gabriel,&nbsp;Ugwoke Peter Ejiofor,&nbsp;Omar Hosea Aske","doi":"10.2174/1872208316666220426120228","DOIUrl":"https://doi.org/10.2174/1872208316666220426120228","url":null,"abstract":"","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"3-8"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9147395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enzymatic Properties of Red Beet (Beta vulgaris L.) Leaf, Root Pulp, and Peel. 红甜菜(Beta vulgaris L.)的酶学性质叶、根、果肉和果皮。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666230201091358
Tatek Sileshi, Zekeria Yusuf, Mulugeta Desta

Background: Beetroot (Beta vulgaris L.) is botanically classified as a herbaceous biennial belonging to the Chenopodiaceae family and has several varieties with bulb colors ranging from yellow to red. Peroxidases are widely occurring in organisms including microorganisms, plants, and animals, and have been involved in various physiological and biochemical functions.

Objective: The study was conducted to investigate the characteristics of enzyme extracts from red beet leaves, root pulp, and peel.

Methods: The enzyme extraction involved the homogenization of the sample and filtrate in cold acetone and then the filtrate was homogenized in 0.1M sodium acetate buffer, pH 7. The protein content was determined using the Lowry assay using bovine serum albumin (BSA) as a standard protein. Then, enzymatic activity was determined by peroxidase, polyphenol oxidase, and catalase assays. The patent for biological activity of enzymes was obtained from the Office of Career Development, Haramaya University. The antioxidant activities of the enzyme extract were conducted by using DPPH and hydrogen peroxide free radical scavenging activities.

Results: The result indicated that the Enzymatic activity of crude enzyme extract of red beet leaf, root pulp and peel indicated that significantly the highest total soluble protein (16.68 mg/ml), peroxidase activity (PODA, 111.50 U/ml), polyphenol oxidase activity (PPOA, 170.90 U/ml), polyphenol oxidase specific activity (PPOspa, 10.25 U/mg), catalase activity (CATA, 180.50 U/ml) and catalase specific activity (CATspa, 10.82 U/mg), were recorded for red beet leaf enzyme extract. The antioxidant activity of the enzyme extracts demonstrated that significantly higher DPPH radical scavenging activity of leaf extract (59.16) and peel extract (61.92) were recorded. The Pearson correlation coefficient of enzyme activity parameters and free radical scavenging activities presented that protein content was significantly and positively correlated with CATA, PPOA, and PPOspa. Catalase- specific activity (CATspa) was significant and positively correlated only with HPSA. Peroxidase-specific activity (PODspa) was significant and positively correlated with PODA and DPPH. Based on the plot for principal component PC2 vs. PC1 for D statistics DPPH, PODA, and PODspa have close PC1 and PC2 scores (with vector angle < 90° showing similar/correlated effects.

Conclusion: In this study, B. vulgaris has shown promising peroxidase enzyme activity. Beetroot peel contained higher antioxidant compounds thus promising a more intense utilization of the peels in food and nutraceuticals.

背景:甜菜根(Beta vulgaris L.)在植物学上被分类为属于藜科的草本二年生植物,有几个品种,球茎颜色从黄色到红色不等。过氧化物酶广泛存在于微生物、植物和动物等生物体内,参与多种生理生化功能。目的:研究红甜菜叶、根浆和果皮的酶提物特性。方法:酶提法将样品和滤液在冷丙酮中均质,滤液在0.1M醋酸钠缓冲液中均质,pH为7。以牛血清白蛋白(BSA)为标准蛋白,采用Lowry法测定蛋白质含量。然后用过氧化物酶、多酚氧化酶和过氧化氢酶测定酶活性。酶的生物活性专利是从原屋大学事业发展办公室获得的。通过DPPH和过氧化氢自由基清除活性对酶提取物的抗氧化活性进行了研究。结果:红甜菜叶、根浆和果皮粗酶提取物的酶活性表明,红甜菜叶粗酶提取物的总可溶性蛋白(16.68 mg/ml)、过氧化物酶活性(PODA, 111.50 U/ml)、多酚氧化酶活性(PPOA, 170.90 U/ml)、多酚氧化酶比活性(PPOspa, 10.25 U/mg)、过氧化氢酶活性(CATA, 180.50 U/ml)和过氧化氢酶比活性(CATspa, 10.82 U/mg)最高。酶提取物的抗氧化活性表明,叶片提取物和果皮提取物的DPPH自由基清除活性分别为59.16和61.92。酶活性参数与自由基清除活性的Pearson相关系数表明,蛋白质含量与CATA、PPOA、PPOspa呈显著正相关。过氧化氢酶特异性活性(CATspa)仅与HPSA呈正相关。过氧化物酶特异性活性(PODspa)与PODA、DPPH呈显著正相关。根据D统计的主成分PC2与PC1的图,DPPH、PODA和PODspa的PC1和PC2得分接近(矢量角< 90°),显示出相似/相关的效果。结论:在本研究中,寻常草具有良好的过氧化物酶活性。甜菜根皮含有较高的抗氧化化合物,因此有望在食品和营养保健品中得到更大的利用。
{"title":"Enzymatic Properties of Red Beet (<i>Beta vulgaris</i> L.) Leaf, Root Pulp, and Peel.","authors":"Tatek Sileshi,&nbsp;Zekeria Yusuf,&nbsp;Mulugeta Desta","doi":"10.2174/1872208317666230201091358","DOIUrl":"https://doi.org/10.2174/1872208317666230201091358","url":null,"abstract":"<p><strong>Background: </strong>Beetroot (Beta vulgaris</i> L.) is botanically classified as a herbaceous biennial belonging to the Chenopodiaceae family and has several varieties with bulb colors ranging from yellow to red. Peroxidases are widely occurring in organisms including microorganisms, plants, and animals, and have been involved in various physiological and biochemical functions.</p><p><strong>Objective: </strong>The study was conducted to investigate the characteristics of enzyme extracts from red beet leaves, root pulp, and peel.</p><p><strong>Methods: </strong>The enzyme extraction involved the homogenization of the sample and filtrate in cold acetone and then the filtrate was homogenized in 0.1M sodium acetate buffer, pH 7. The protein content was determined using the Lowry assay using bovine serum albumin (BSA) as a standard protein. Then, enzymatic activity was determined by peroxidase, polyphenol oxidase, and catalase assays. The patent for biological activity of enzymes was obtained from the Office of Career Development, Haramaya University. The antioxidant activities of the enzyme extract were conducted by using DPPH and hydrogen peroxide free radical scavenging activities.</p><p><strong>Results: </strong>The result indicated that the Enzymatic activity of crude enzyme extract of red beet leaf, root pulp and peel indicated that significantly the highest total soluble protein (16.68 mg/ml), peroxidase activity (PODA, 111.50 U/ml), polyphenol oxidase activity (PPOA, 170.90 U/ml), polyphenol oxidase specific activity (PPOspa, 10.25 U/mg), catalase activity (CATA, 180.50 U/ml) and catalase specific activity (CATspa, 10.82 U/mg), were recorded for red beet leaf enzyme extract. The antioxidant activity of the enzyme extracts demonstrated that significantly higher DPPH radical scavenging activity of leaf extract (59.16) and peel extract (61.92) were recorded. The Pearson correlation coefficient of enzyme activity parameters and free radical scavenging activities presented that protein content was significantly and positively correlated with CATA, PPOA, and PPOspa. Catalase- specific activity (CATspa) was significant and positively correlated only with HPSA. Peroxidase-specific activity (PODspa) was significant and positively correlated with PODA and DPPH. Based on the plot for principal component PC2 vs. PC1 for D statistics DPPH, PODA, and PODspa have close PC1 and PC2 scores (with vector angle < 90° showing similar/correlated effects.</p><p><strong>Conclusion: </strong>In this study, B. vulgaris</i> has shown promising peroxidase enzyme activity. Beetroot peel contained higher antioxidant compounds thus promising a more intense utilization of the peels in food and nutraceuticals.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 4","pages":"395-404"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9533325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Status and Medicinal Prominence of Arnebia euchroma (Ratanjot): A Critically Endangered Plant of Trans-Himalayan Region. 跨喜玛拉雅地区极危植物紫金蒿的现状及药用价值。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220718154341
Sunita Devi, Pooja Sharma, Rohini Sharma, Meena Thakur

Trans-Himalayan region has been a major component of the India's opulent medicinal plant heritage that encompasses numerous critically endangered plant species. Arnebia euchroma (Royle ex Benth.) Johnston (common name: Ratanjot), a Trans- Himalayan native, is amongst them, and it belongs to the family Boraginaceae. Ratanjot has long been used as a colourant in food and cosmetics besides a major ingredient of traditional remedies prescribed for curing mild constipation, dermatitis, frostbite, and eczema like health disorders. Though principally harvested for its roots, almost all the parts of this plant have been used in pharmaceutical products, food, dyes and beverages since prehistoric times. Its roots are a rich source of naphthoquinone pigment(s) mainly shikonin, acetylshikonin and deoxyshikonin, accountable for its medicinal value as antimicrobial, wound healing, anti-inflammatory, anticancer, and antioxidant agent(s). Considering the medicinal importance and critically endangered status of this taxon, the need of the hour is to conserve and propagate it for supplying sufficient raw materials for its commercial exploitation.

跨喜马拉雅地区一直是印度丰富的药用植物遗产的主要组成部分,其中包括许多极度濒危的植物物种。赤藓(Royle ex Benth.)Johnston(俗称Ratanjot),一种跨喜马拉雅的原生植物,就是其中之一,它属于Boraginaceae家族。Ratanjot长期以来一直被用作食品和化妆品的着色剂,也是治疗轻度便秘、皮炎、冻伤和湿疹等健康疾病的传统疗法的主要成分。虽然主要收获它的根,但自史前时代以来,这种植物的几乎所有部分都被用于制药产品、食品、染料和饮料。其根是萘醌色素的丰富来源,主要是紫草素、乙酰紫草素和脱氧紫草素,具有抗菌、伤口愈合、抗炎、抗癌和抗氧化剂的药用价值。考虑到这一分类群的药用价值和极度濒危的地位,当务之急是保护和繁殖它,为其商业开发提供足够的原料。
{"title":"Current Status and Medicinal Prominence of <i>Arnebia euchroma</i> (Ratanjot): A Critically Endangered Plant of Trans-Himalayan Region.","authors":"Sunita Devi,&nbsp;Pooja Sharma,&nbsp;Rohini Sharma,&nbsp;Meena Thakur","doi":"10.2174/1872208316666220718154341","DOIUrl":"https://doi.org/10.2174/1872208316666220718154341","url":null,"abstract":"<p><p>Trans-Himalayan region has been a major component of the India's opulent medicinal plant heritage that encompasses numerous critically endangered plant species. Arnebia euchroma (Royle ex Benth.) Johnston (common name: Ratanjot), a Trans- Himalayan native, is amongst them, and it belongs to the family Boraginaceae. Ratanjot has long been used as a colourant in food and cosmetics besides a major ingredient of traditional remedies prescribed for curing mild constipation, dermatitis, frostbite, and eczema like health disorders. Though principally harvested for its roots, almost all the parts of this plant have been used in pharmaceutical products, food, dyes and beverages since prehistoric times. Its roots are a rich source of naphthoquinone pigment(s) mainly shikonin, acetylshikonin and deoxyshikonin, accountable for its medicinal value as antimicrobial, wound healing, anti-inflammatory, anticancer, and antioxidant agent(s). Considering the medicinal importance and critically endangered status of this taxon, the need of the hour is to conserve and propagate it for supplying sufficient raw materials for its commercial exploitation.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"92-102"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9434213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Levothyroxine Sodium - Thyroid Hormone Replacement Therapy for Hypothyroidism: A Review of Patent Literature. 左旋甲状腺素钠-甲状腺激素替代疗法治疗甲状腺功能减退:专利文献综述。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666221212124113
Uddeshya Upadhyay, Pratik Ashwinbhai Vora, Rakesh Patel, Bijal Prajapati

Background: Levothyroxine Sodium is a thyroid hormone replacement therapy for Hypothyroidism. Levothyroxine Sodium is approved to treat Hypothyroidisim, to suppress thyroid hormone release from cancerous thyroid nodules, and to prevent the growth of goiters. In addition, it is also used to treat conditions such as myxedema, cretinism, and obesity.

Objective: This assessment highlights the overview of the recent patents of Levothyroxine Sodium. This review includes patents grouped in sections like product patents, process patents, and composition-related patents, along with the treatment methodology. The objective of this article is to impel pseudoscientists to all existing patents in a solitary place.

Methods: Data were gathered from various internet-based resources, including Patentscope ® (WIPO), Worldwide Espacenet® (EPO), Google Patents, and InPASS (Indian patent database).

Results: Several new processes and composition-related patents of Levothyroxine Sodium have been reported. Further, due to the problem of photosensitivity, oxidation during development, and stability of Levothyroxine Sodium formulation, several excipients are tried in these patents to stabilize the same. However, the formulation of Levothyroxine Sodium with better characteristics needs to be developed.

Conclusion: Extensive exposure has been carried out towards various processes for the preparation of Levothyroxine Sodium and the composition of the same. This sort of dynamic exploration will clear the path for many generic players, which will lead to the reduction of the expense of the composition and accordingly enhance global health care at a less expensive cost.

背景:左旋甲状腺素钠是治疗甲状腺功能减退症的一种甲状腺激素替代疗法。左甲状腺素钠被批准用于治疗甲状腺功能减退症,抑制甲状腺癌结节释放甲状腺激素,防止甲状腺肿的生长。此外,它还用于治疗黏液性水肿、克汀病和肥胖等疾病。目的:对近年来有关左甲状腺素钠的专利进行综述。本综述包括产品专利、工艺专利和成分相关专利等部分的专利,以及处理方法。这篇文章的目的是促使伪科学家在一个孤立的地方获得所有现有的专利。方法:数据收集自各种基于互联网的资源,包括Patentscope®(WIPO)、Worldwide Espacenet®(EPO)、Google Patents和InPASS(印度专利数据库)。结果:报道了几种左甲状腺素钠的新工艺和成分相关专利。此外,由于左甲状腺素钠的光敏性、显影过程中的氧化和稳定性问题,在这些专利中尝试了几种赋形剂来稳定左甲状腺素钠。然而,性能较好的左甲状腺素钠的配方还有待开发。结论:对左甲状腺素钠的各种制备工艺及其组成进行了广泛的接触。这种动态探索将为许多非专利药参与者扫清道路,这将导致减少药物组合的费用,从而以较低的成本加强全球卫生保健。
{"title":"Levothyroxine Sodium - Thyroid Hormone Replacement Therapy for Hypothyroidism: A Review of Patent Literature.","authors":"Uddeshya Upadhyay,&nbsp;Pratik Ashwinbhai Vora,&nbsp;Rakesh Patel,&nbsp;Bijal Prajapati","doi":"10.2174/1872208317666221212124113","DOIUrl":"https://doi.org/10.2174/1872208317666221212124113","url":null,"abstract":"<p><strong>Background: </strong>Levothyroxine Sodium is a thyroid hormone replacement therapy for Hypothyroidism. Levothyroxine Sodium is approved to treat Hypothyroidisim, to suppress thyroid hormone release from cancerous thyroid nodules, and to prevent the growth of goiters. In addition, it is also used to treat conditions such as myxedema, cretinism, and obesity.</p><p><strong>Objective: </strong>This assessment highlights the overview of the recent patents of Levothyroxine Sodium. This review includes patents grouped in sections like product patents, process patents, and composition-related patents, along with the treatment methodology. The objective of this article is to impel pseudoscientists to all existing patents in a solitary place.</p><p><strong>Methods: </strong>Data were gathered from various internet-based resources, including Patentscope ® (WIPO), Worldwide Espacenet® (EPO), Google Patents, and InPASS (Indian patent database).</p><p><strong>Results: </strong>Several new processes and composition-related patents of Levothyroxine Sodium have been reported. Further, due to the problem of photosensitivity, oxidation during development, and stability of Levothyroxine Sodium formulation, several excipients are tried in these patents to stabilize the same. However, the formulation of Levothyroxine Sodium with better characteristics needs to be developed.</p><p><strong>Conclusion: </strong>Extensive exposure has been carried out towards various processes for the preparation of Levothyroxine Sodium and the composition of the same. This sort of dynamic exploration will clear the path for many generic players, which will lead to the reduction of the expense of the composition and accordingly enhance global health care at a less expensive cost.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 3","pages":"245-256"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9466156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Recent patents on biotechnology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1